Childhood diabetes: epidemiology, risk factors and approach to acute complications

Abstract

Epilepsy is a chronic neurological condition that affects millions of people worldwide. The search for effective treatments has been ongoing, leading to investigations into alternative therapies, including the use of cannabis. This review examines the current evidence on the efficacy and safety of cannabis use in the treatment of epilepsy. The aim of this review is to assess the latest research related to the use of cannabis in the treatment of epilepsy. We sought to identify emerging trends, highlight the main scientific advances and provide an overview of the clinical implications for the use of cannabis in this context. To achieve the proposed objectives, an extensive literature search was carried out using renowned scientific databases. Clinical studies, randomized controlled trials, systematic reviews and meta-analyses investigating the use of cannabis or its derivatives for the treatment of epilepsy were included. The data was analyzed systematically, allowing a critical assessment of the methodological quality and results obtained in each study. The analysis of the selected studies reveals a growing body of evidence suggesting the therapeutic potential of cannabis in the management of epilepsy. In addition, an improvement in quality of life and tolerability has been observed in certain cases. However, it is important to note that the efficacy of cannabis in the treatment of epilepsy can vary according to the type of epilepsy, the dosage, the formulation of the product and the individual response of the patient. In addition, concerns related to side effects and long-term safety have also been discussed in some studies.